Skip to main content
. 2020 Feb 20;2020:4631297. doi: 10.1155/2020/4631297

Table 2.

Exposure to immunosuppressants before diagnosis of PCP.

Immunosuppressants N = 50
CTX 24 (48%)
CsA 10 (20%)
MMF 4 (8%)
FK506 2 (4%)
MTX 1 (2%)
TwHF 1 (2%)
LEF 1 (2%)
CTX + CsA 3 (6%)
CTX + TwHF 2 (4%)
CTX + MMF 1 (2%)
CTX + HCQ 1 (2%)

CTX: cyclophosphamide, CsA: cyclosporine A, MMF: mycophenolate mofetil, FK506: tacrolimus, MTX: methotrexate, TwHF: tripterygium wilfordii hook F, LEF: leflunomide, and HCQ: hydroxychloroquine. Data were presented as numbers (%).